12. INSULINOTERAPIA June 13, 2008 NEJM Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial * stopped earlier this year because of an increased mortality in the intensive group, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE)